On the one hand, the FNDC4-GPR116 axis is damaged in patients with diabetes; on the other hand, injection of recombinant FcsFNDC4 corrected hyperglycemia in prediabetic mice by inducing the GPR116-Gs-cAMP signaling pathway in adipocytes.68 This evidence concerns the gene ADGRF5 and Hyperglycemia.